Sanofi Strikes Deal To Develop Respiratory Health App
Sanofi Consumer Healthcare is working with digital health firm ResApp to develop a mobile application which consumers can use to diagnose and manage respiratory illnesses. Such a tool has the potential to support novel Rx-to-OTC switch applications in future.
Sanofi Consumer Healthcare has entered into collaboration with Australia’s ResApp Health to develop a smartphone application for the diagnosis and management of respiratory disease.
ResApp – a digital health company developing apps for the diagnosis of respiratory illness – has granted Sanofi the option...